e-learning
resources
Munich 2006
Saturday 02.09.2006
PG3 - Update on occupational and environmental lung disease, including "bring your own cases" for interactive discussion
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD: causal factors other than active smoking
K. Toren (Goteborg, Sweden)
Source:
Annual Congress 2006 - PG3 - Update on occupational and environmental lung disease, including "bring your own cases" for interactive discussion
Session:
PG3 - Update on occupational and environmental lung disease, including "bring your own cases" for interactive discussion
Session type:
Postgraduate Course
Number:
72
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Toren (Goteborg, Sweden). COPD: causal factors other than active smoking. Annual Congress 2006 - PG3 - Update on occupational and environmental lung disease, including "bring your own cases" for interactive discussion
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The influence of smoking on COPD phenotypes
Source: Eur Respir J 2004; 24: Suppl. 48, 20s
Year: 2004
COPD disease progression and airway inflammation: uncoupled by smoking cessation
Source: Eur Respir J 2005; 26: 764-766
Year: 2005
CD8+ve airway inflammation in COPD: The impact of smoking status
Source: Annual Congress 2003 - Cigarette smoke: how it does its dirty work
Year: 2003
Passive and active smoking in childhood for COPD
Source: Annual Congress 2005 - Does COPD begin in childhood? Reviewing the evidence
Year: 2005
The tobacco smoking influence on parodontic inflammation in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 167s
Year: 2007
Risk factors of bronchial hyperresponsiveness in COPD
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories
Source: Eur Respir J, 58 (5) 2004656; 10.1183/13993003.04656-2020
Year: 2021
Evidence for harm reduction in diseased smokers
Source: Annual Congress 2007 - Targeting smokers by reduction: the "snus" connection revisited
Year: 2007
Environmental tobacco smoke exposure and the risk of obstructive lung disease exacerbation
Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease
Year: 2005
Lung cancer: causal factors other than active smoking
Source: Annual Congress 2006 - PG3 - Update on occupational and environmental lung disease, including "bring your own cases" for interactive discussion
Year: 2006
Developing COPD – a 25 year follow-up study of the general population
Source: Annual Congress 2005 - Better understanding of lung function decline and COPD
Year: 2005
The effect of smoking on the activity of inflammatory markers in patients with COPD
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013
Overview of smoking-related disease
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis
Source: Eur Respir J 2007; 30: 467-471
Year: 2007
Beyond personal smoking: does environmental tobacco smoke cause chronic obstructive pulmonary disease?
Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease
Year: 2005
COPD patients‘ response to smoking cessation
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005
The influence of smoking on hydrolipoperoxidation in COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 306s
Year: 2003
Tobacco use in relation to COPD and asthma
Source: Eur Respir J 2007; 29: 438-445
Year: 2007
Do childhood factors and asthma modify the impact of smoking on COPD?
Source: Annual Congress 2010 - Risk factors for asthma in children and adults including severe disease
Year: 2010
Interaction between smoking and genetic factors in the development of chronic bronchitis
Source: Eur Respir J 2003; 22: Suppl. 45, 388s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept